238.58MMarket Cap-2.37P/E (TTM)
3.7300High3.4800Low1.04MVolume3.7300Open3.7200Pre Close3.71MTurnover2.34%Turnover RatioLossP/E (Static)67.59MShares19.050052wk High0.73P/B157.10MFloat Cap2.700052wk Low--Dividend TTM44.51MShs Float85.0000Historical High--Div YieldTTM6.72%Amplitude0.0300Historical Low3.5620Avg Price1Lot Size
Perspective Therapeutics Stock Forum
I don't even trust my mind
losing everybody
they can never take my grind
📊⚡️📊
Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
Perspective Therapeutics (NYSE AMERICAN: CATX) announced the upcoming presentation of initial results from their Phase 1/2a trial of [212Pb]VMT-α-NET at the 2024 NANETS Multidisciplinary NET Medical Symposium. The presentation, titled 'Preliminary safety and eff...
Larger Image: tradingview.com...
$Perspective Therapeutics (CATX.US)$
No comment yet